期刊文献+

非小细胞肺癌患者外周血Th17和Treg表达的意义 被引量:11

Expression and significance of Th17 and Treg in peripheral blood of non-small cell lung cancer
在线阅读 下载PDF
导出
摘要 目的 研究非小细胞肺癌(non-small cell lung cancer,NSCLC)患者外周血中辅助性T细胞17(T help cell 17,Th17)与调节性T淋巴细胞(T regular cell,Treg)表达及平衡关系的变化,探讨其在NSCLC发病机制中的作用.方法 应用流式细胞术检测60例NSCLC患者和31例健康对照外周血Th17和Treg的表达及平衡关系的变化.结果 NSCLC患者外周血Th17表达明显高于健康对照组[(3.40%±0.49%) vs.(2.16%±0.39%),P<0.001],但腺癌与鳞癌组及进展期(Ⅳ期)与局限期(Ⅰ~Ⅲ期)组Th17无明显差异.NSCLC患者外周血Treg表达与健康对照相比也有显著升高[(7.76%±1.58%) vs.(4.40%±1.08%),P<0.001],并且进展期较局限期组Treg表达明显升高[(8.16%±1.56%) vs.(6.97%±1.35%),P=0.005].腺癌组与鳞癌组Treg表达无明显差异.NSCLC组Treg/Th17较健康对照组明显增高[(2.36±0.73) vs.(2.05±0.46),P=0.038],并且进展期较局限期组进一步升高[(2.53±0.78) vs.(2.03±0.51),P=0.012].结论 NSCLC患者可能存在Treg/Th17的失衡,而Treg/Th17比值的变化也与NSCLC的预后相关. Objective To observe the changes and imbalance of T help cell 17 (Th17) and T regular cell (Treg) in peripheral blood of patients with non-small cell lung cancer (NSCLC).Methods Peripheral bloods were collected from 60 patients with NSCLC and 31 healthy subjects.The percentages of Th17 and Treg in peripheral blood were detected by flow cytometry.Results The percentage of Th17 in peripheral blood was significantly increased in patients with NSCLC compared with the controls [(3.40% ± 0.49%) vs.(2.16% ± 0.39%),P<0.001],but there was no difference in the subgroups of NSCLC no matter when classify with tumor type or tumor stage.The percentage of Treg in peripheral blood was also significantly higher in patients with NSCLC compared with the control [(7.76% ± 1.58%) vs.(4.40% ± 1.08%),P<0.001].Moreover,the patients in advanced stage had higher percentage of Treg compared with those in limited stage [(8.16% ± 1.56%) vs.(6.97% ± 1.35%),P =0.005].The ratio of Treg and Th17 (Treg/Th17) in patients with NSCLC was increased greatly compared with the controls [(2.36 ± 0.73) vs.(2.05 ± 0.46),P =0.038].Moreover,the Treg/Th17 ratio also increased in the patients in advanced stage.Conclusions The Th17/Treg imbalance might play a critical role in the pathogenesis of NSCLC,which could be an important factor correlated with the prognosis of NSCLC.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2015年第3期362-367,共6页 Fudan University Journal of Medical Sciences
基金 上海市卫生局科技基金(20114307) 上海市科委自然基金生物引导类项目(134119b1200) 上海市卫生系统优秀学科带头人培养计划(XBR2013078)~~
关键词 非小细胞肺癌 辅助性T细胞17 调节性T淋巴细胞 non-small cell lung cancer T help cell 17 T regular cell
作者简介 Corresponding author E-mail:jiezjlxh@163.com
  • 相关文献

参考文献15

  • 1陈万青,张思维,邹小农.中国肺癌发病死亡的估计和流行趋势研究[J].中国肺癌杂志,2010,13(5):488-493. 被引量:519
  • 2汪济东,姜庆玲,孙琦,张扬,张建中.Ⅲb+Ⅳ期晚期肺癌治疗效果分析[J].临床肺科杂志,2013,18(4):705-706. 被引量:3
  • 3Rajatava B,Robin D, Casey T, et al. The Th17 family: flexibility follows function [J]. Immunol Rev, 2013,252 (1) 89 - 103.
  • 4Khazaie K,von Boehmer H. The impact of CD4* CD25 Treg on tumor cytotoxicity and cancer[J]. Semin Cancer Bio1,2006,16(2) :124 - 136.
  • 5Numasaki M, Fukushi J, Ono M, et al. Interleukiwl7 promotes angiogenesis and tumor growth [J]. Blood, 2003,101(7) :2620 - 2627.
  • 6Wang L,Yi T, Kortylewski M, et al. IL-17 can promote tumor growth through an IL-6-Star3 signaling pathway [J]. J Exp Med ,2009,206(7) : 1457 - 1464.
  • 7Muranski P, Boni A, Antony PA, et al. Tumor specific Thl7 polarized cells eradicate large established melanoma [J]. Blood,2008,112(2) :362 -373.
  • 8Martin-Orozco N, Muranski P, Chung Y,et al. T helper 17 cells promote cytotoxic T cell activation in tumor immunity[J]. Immunity, 2009,31 (5) : 787 - 798.
  • 9Whiteside TL. What are regulatory T cells (Treg) regulating in cancer and why? [J]. Semin Cancer Biol, 2012,22(4) :327 - 334.
  • 10Yoshiko T, Yasunari N, Akiko N, et al. Frequency of CD45RO+ subset in CD4+ CD25hi*h regulatory T, cells associated with progression of hepatocellular carcinoma [J]. Cancer Lett ,2011,307(2) : 165 - 173.

二级参考文献30

共引文献520

同被引文献130

  • 1陈理明,李晓洁,蔡应木,王少彬,陈俊辉.肝癌肺癌患者射频消融治疗后细胞免疫功能变化[J].实用医学杂志,2006,22(21):2467-2468. 被引量:11
  • 2何维.医学免疫学[M].2版.北京:人民卫生出版社,2010:414.
  • 3Dupuy DE,Zagoria RJ,Akerley W,et al.Percutaneous ra- diofrequency ablation of malignancies in the lung[J].Am J Roentgenol, 2000, 174( 1 ) : 57-59.
  • 4Zhu JF, Paul WE.CD4 T cells : fates, functions, and faults [J].Blood, 2008,12(5) : 1557-1569.
  • 5Ivanova EA, Orekhov AN.T helper lymphocyte subsets and plasticity in autoimmunity and cancer:an overview [J]. Biomed Res Int, 2015,2015 : 327470.
  • 6Gasper DJ,Tejera MM, Suresh M.CD4 T-cell memory generation and maintenance[J].Crit Rev Immunol,2014,34(2) : 121-146.
  • 7Boost KA,Sadik CD,Bachmann M,et al.IFN-gamma im- pairs release of IL-8 by IL-lbeta-stimulated A549 lung carcinoma cells[J].BMC Cancer, 2008, (8) : 265.
  • 8Li J,Wang Z,Mao K,et al.Clinical significance of serum T helper 1/T helper 2 cytokine shift in patients with non- small cell lung cancer[J].Oncol Lett,2014,8 (4): 1682- 1686.
  • 9Nguyen AH, Berim IG,Agrawal DK.Cellular and molec- ular immunology of lung cancer:therapeutic implications [J].Expert Rev Clin Immunol, 2014, 10(12) : 1711-1730.
  • 10Pan B, Shen J, Cao J,et al.Interleukin- 17 promotes angio- genesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer[J].Sci Rep, 2015, (5) : 16053.

引证文献11

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部